Evidence map›Paper›PMID 32054616›Full record

ArticleAJNR. American journal of neuroradiology2020

SWAN-Venule: An Optimized MRI Technique to Detect the Central Vein Sign in MS Plaques.

M I Gaitán, P Yañez, M E Paday Formenti, I Calandri, E Figueiredo, P Sati, J Correale

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Factors for Rituximab Refractoriness in AQP4-IgG+ NMOSD: A Cohort Study.Annals of clinical and translational neurology · 2025
    Article
  3. Article
  4. Review
  5. Misdiagnosis of Multiple Sclerosis: Past, Present, and Future.Current neurology and neuroscience reports · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

M I GaitánFrom the Department of Neurology (M.I.G., J.C.), Neuroimmunolgy Section minesgaitan@gmail.com migaitan@fleni.org.ar.ORCID 0000-0003-4455-5641
P YañezDepartments of Radiology (P.Y., M.E.P.F.).ORCID 0000-0002-3378-7378
M E Paday FormentiDepartments of Radiology (P.Y., M.E.P.F.).ORCID 0000-0001-9776-1882
I CalandriNeurology (I.C.), FLENI, Buenos Aires, Argentina.ORCID 0000-0002-6983-1430
E FigueiredoGE healthcare (E.F.), Sao Paulo, Brazil.ORCID 0000-0002-3440-0737
P SatiTranslational Neuroradiology Section (P.S.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-9325-3570
J CorrealeFrom the Department of Neurology (M.I.G., J.C.), Neuroimmunolgy Section.ORCID 0000-0003-4756-9889
Institute of Neuroimmunology of the Slovak Academy of Sciences · SKPower+Energy (United States) · USFundación para la Lucha contra las Enfermedades Neurológicas de la Infancia · ARGeneral Electric (Spain) · ESNational Institute of Neurological Disorders and Stroke · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMultiple sclerosis lesions develop around small veins that are radiologically described as the so-called central vein sign. With 7T MR imaging and magnetic susceptibility-based sequences, the central vein sign has been observed in 80%-100% of MS lesions in patients' brains. However, a lower proportion ∼50% has been reported at 3T using susceptibility-weighted angiography (SWAN). Our aim was to assess a modified version of SWAN optimized at 3T for sensitive detection of the central vein sign. MATERIALS AND

methodsThirty subjects with MS were scanned on a 3T clinical MR imaging system. 3D T2-weighted FLAIR and optimized 3D SWAN called SWAN-venule, were acquired after injection of a gadolinium-based contrast agent. Patients showing >3 focal white matter lesions were included. The central vein sign was recorded by 2 trained raters on SWAN-venule images in the supratentorial brain.

resultsTwenty patients showing >3 white matter lesions were included. A total of 380 white matter lesions (135 periventricular, 144 deep white matter, and 101 juxtacortical) seen on both FLAIR and SWAN-venule images were analyzed. Overall, the central vein sign was detected in 86% of the white matter lesions (periventricular, 89%; deep white matter, 95%; and juxtacortical, 78%).

conclusionsThe SWAN-venule technique is an optimized MR imaging sequence for highly sensitive detection of the central vein sign in MS brain lesions. This work will facilitate the validation and integration of the central vein sign to increase the diagnostic certainty of MS and further prevent misdiagnosis in clinical practice.

Indexed as

AdultCerebral AngiographyFemaleHumansMagnetic Resonance AngiographyMaleMultiple SclerosisNeuroimagingVenulesWhite Matter

Identifiers

PMID32054616
PMCPMC7077907
OpenAlexW3006175655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.